Anetumab Ravtansine Versus Vinorelbine in Patients with Relapsed, Mesothelin-Positive Malignant Pleural Mesothelioma (ARCS-M): a Randomised, Open-Label Phase 2 Trial.Hedy L. Kindler,Silvia Novello,Alessandra Bearz,Giovanni L. Ceresoli,Joachim G. J. Aerts,James Spicer,Paul Taylor,Kristiaan Nackaerts,Alastair Greystoke,Ross Jennens,Luana Calabro,Jacobus A. Burgers,Armando Santoro,Susana Cedres,Piotr Serwatowski,Santiago Ponce,Jan P. Van Meerbeeck,Anna K. Nowak,George Biumenschein,Jonathan M. Siegel,Linda Kasten,Karl Koechert,Annette O. Walter,Barrett H. Childs,Cem Elbi,Raffit Hassan,Dean A. FennellLancet oncology/Lancet Oncology（2022）引用 18|浏览53暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
